Download PDF
Klin Monbl Augenheilkd 2012; 229(4): 407-410
DOI: 10.1055/s-0031-1299271
Kasuistik
© Georg Thieme Verlag KG Stuttgart · New York

Schwere Tamponade bei komplizierten inferioren Netzhautablösungen

Heavy Tamponade in Complicated Inferior Retinal Detachment
M. Brunner
,
C. Lang
,
C. Valmaggia
Further Information

Publication History

Publication Date:
11 April 2012 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Hintergrund: Inferiore Netzhautablösungen mit proliferativer Vitreoretinopathie sind schwierig zu behandeln. Ziel dieser Fallserie war die Beurteilung der Effizienz und Zuverlässigkeit von Densiron bei der Behandlung von komplizierten Netzhautablösungen.

Anamnese und Befunde: 6 Augen von 6 Patienten mit Netzhautablösung und inferiorer proliferativer Vitreoretinopathie Grad 3 wurden mittels Pars-plana-Vitrektomie und Injektion von Densiron behandelt. Die Patienten waren durchschnittlich 61 Jahre alt. 3 Patienten hatten bereits einen erfolglosen vitreoretinalen Eingriff im Vorfeld und bei 3 Patienten wurde Densiron beim ersten vitreoretinalen Eingriff angewandt. Die mittlere Ausdehnung der Netzhautablösung erstreckte sich über mindestens 2 Quadranten mit einer Makulabeteiligung in 3 Fällen. Der durchschnittliche Visus präoperativ betrug 29,2 ETDRS. 

Therapie und Verlauf: Densiron wurde nach durchschnittlich 58 Tagen entfernt. Bei 5 Patienten zeigte sich eine Wiederanlage der Netzhaut ohne weitere Tamponade, in einem Fall erst nach erneuter Injektion von konventionellem Silikonöl. 4 – 6 Wochen postoperativ betrug der durchschnittliche Visus 50,2 ETDRS. Die häufigste Komplikation war ein Anstieg des Augendrucks, welcher sich nach Entfernung des Densirons normalisierte.

Schlussfolgerungen: Densiron verbessert die Tamponade der inferioren Netzhaut. Demzufolge könnte die klinische Anwendung in ausgewählten Fällen zur erfolgreichen Behandlung von komplizierten Netzhautablösungen mit inferiorer proliferativer Vitreoretinopathie beitragen.

Abstract

Background: Retinal detachment with inferior proliferative vitreoretinopathy is a difficult to treat problem. The aim of our study was to assess the safety and efficacy of Densiron in the clinical management of complicated retinal detachment.

History and Signs: 6 eyes of 6 consecutive patients presenting with a retinal detachment with inferior proliferative vitreoretinopathy grade 3 were treated with pars plana vitrectomy and injection of Densiron. The mean age of the patients was 61 years. 3 patients had a previous unsuccessful vitreoretinal surgery and 3 patients had Densiron as a first procedure. The extent of detachment was at least 2 or more quadrants with macular involvement in 3 cases. Preoperatively the mean visual acuity was 29.2 letters with ETDRS. 

Therapy and Outcome: Densiron was removed after an average of 58 days. 5 patients achieved retinal re-attachment without further tamponade, and 1 patient after additional injection of conventional silicon oil. 4 – 6 weeks after removal of Densiron the mean visual acuity was 50.2 letters with ETDRS. The most common complication was an elevated intraocular pressure during endotamponade, which resolved following removal of the agent.

Conclusions: Densiron improves inferior tamponade, and in clinical practice may be considered to increase the anatomic success rate in selected cases of complicated retinal detachment with inferior proliferative vitreoretinopathy.

Schlüsselwörter

Densiron - schwere Tamponade - komplizierte inferiore Netzhautablösung - proliferative Vitreoretinopathie

Key words

Densiron - heavy tamponade - complicated inferior retinal detachment - proliferative vitreoretinopathy
 

  • Literatur

  • 1 Joussen AM, Kirchhof B, Schrage N et al. Heavy silicone oil versus standard silicone oil as vitreous tamponade in inferior PVR (HSO Study): design issues and implications. Acta Ophthalmol Scand 2007; 85: 623-630
    CrossrefPubMedGoogle Scholar
  • 2 Cazabon S, Hillier RJ, Wong D. Heavy silicone oil: a „novel“ intraocular tamponade agent. Optom Vis Sci 2011; 88: 772-775
    CrossrefPubMedGoogle Scholar
  • 3 Heimann H, Stappler T, Wong D. Heavy tamponade 1: a review of indications, use, and complications. Eye 2008; 22: 1342-1359
    CrossrefPubMedGoogle Scholar
  • 4 Joussen AM, Kugler W, Lingenfelder C. Heavy tamponades – background and future perspectives. Klin Monatsbl Augenheilkd 2009; 226: 693-698
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Duan A, She H, Qi Y. Complications after heavy silicone oil tamponade in complicated retinal detachment. Retina 2011; 31: 547-552
    CrossrefPubMedGoogle Scholar
  • 6 Abdelkader E, Siddiqui RM, Ramalingam S et al. Heavier-than-water silicone oil mixture as a long-term tamponade agent: a pilot study. Ophthalmologica 2011; 226 (Suppl. 01) 60-65
    CrossrefPubMedGoogle Scholar
  • 7 Gerding H, Timmermann M, Hefner L et al. Heavy internal tamponade for cases with complicated retinal detachment. Klin Monatsbl Augenheilkd 2011; 228: 273-276
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Er H. Primary heavy silicone oil usage in inferior rhegmatogenous retinal detachment. Ophthalmologica 2010; 224: 122-125
    CrossrefPubMedGoogle Scholar
  • 9 Romano M, Stappler T, Marticorena J et al. Primary vitrectomy with Densiron-68 for rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1541-1546
    CrossrefPubMedGoogle Scholar
  • 10 Sandner D, Engelmann K. First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment. Graefes Arch Clin Exp Ophthalmol 2006; 244: 609-619
    CrossrefPubMedGoogle Scholar
  • 11 Lim B, Vote B. Densiron intraocular tamponade: a case series. Clin Experiment Ophthalmol 2008; 36: 261-264
    CrossrefPubMedGoogle Scholar
  • 12 Regler R, Sachs HG, Hillenkamp J et al. Long-term evaluation of anatomic and functional results after complicated retinal detachment treated with pars plana vitrectomy and heavy silicone oil tamponade. Klin Monatsbl Augenheilkd 2009; 226: 707-712
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Federman JL, Schubert HD. Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology 1988; 95: 870-876
    PubMedGoogle Scholar
  • 14 Van Meurs JC, Mertens DA, Peperkamp E et al. Five-year results of vitrectomy and silicone oil in patients with proliferative vitreoretinopathy. Retina 1993; 13: 285-289
    CrossrefPubMedGoogle Scholar
  • 15 Jonas JB, Knorr HL, Rank RM et al. Retinal redetachment after removal of intraocular silicone oil tamponade. Br J Ophthalmol 2001; 85: 1203-1207
    CrossrefPubMedGoogle Scholar
  • 16 Wickham L, Connor M, Aylward GW. Vitrectomy and gas for inferior break retinal detachments: are the results comparable to vitrectomy, gas, and scleral buckle?. Br J Ophthalmol 2004; 88: 1376-1379
    CrossrefPubMedGoogle Scholar
  • 17 Mokete B, Williamson TH. Scleral buckling combined with vitrectomy for the management of rhegmatogenous retinal detachment associated with inferior retinal breaks. Eye 2009; 23: 1233; author reply: 1233-1234
    PubMedGoogle Scholar
  • 18 Alexander P, Ang A, Poulson A et al. Scleral buckling combined with vitrectomy for the management of rhegmatogenous retinal detachment associated with inferior retinal breaks. Eye 2008; 22: 200-203
    CrossrefPubMedGoogle Scholar
  • 19 Tabandeh H, Sullivan PM, Smahliuk P et al. Suprachoroidal hemorrhage during pars plana vitrectomy. Risk factors and outcomes. Ophthalmology 1999; 106: 236-242
    CrossrefPubMedGoogle Scholar
  • 20 Flindall RJ, Norton EW, Curtin VT et al. Reduction of extrusion and infection following episcleral silicone implants and cryopexy in retinal detachment surgery. Am J Ophthalmol 1971; 71: 835-837
    PubMedGoogle Scholar
  • 21 Sato EA, Shinoda K, Inoue M et al. Reduced choroidal blood flow can induce visual field defect in open angle glaucoma patients without intraocular pressure elevation following encircling scleral buckling. Retina 2008; 28: 493-497
    CrossrefPubMedGoogle Scholar
  • 22 Goezinne F, La Heij EC, Berendschot TT et al. Anterior chamber depth is significantly decreased after scleral buckling surgery. Ophthalmology 2010; 117: 79-85
    CrossrefPubMedGoogle Scholar
  • 23 Kwartz J, Charles S, McCormack P et al. Anterior segment ischaemia following segmental scleral buckling. Br J Ophthalmol 1994; 78: 409-410
    CrossrefPubMedGoogle Scholar
  • 24 Hayashi H, Hayashi K, Nakao F et al. Corneal shape changes after scleral buckling surgery. Ophthalmology 1997; 104: 831-837
    PubMedGoogle Scholar
  • 25 Leibovitch I, Crompton J, Selva D. New onset diplopia: 14 years after retinal detachment surgery with a hydrogel scleral buckle. Br J Ophthalmol 2005; 89: 640
    PubMedGoogle Scholar
  • 26 Romano MR, Angi M, Valldeperas X et al. Twenty-three-gauge pars plana vitrectomy, Densiron-68, and 360° endolaser versus combined 20-gauge pars plana vitrectomy, scleral buckle, and SF6 for pseudophakic retinal detachment with inferior retinal breaks. Retina 2011; 31: 686-691
    PubMedGoogle Scholar
  • 27 Wong D, Kumar I, Quah S et al. Comparison of postoperative intraocular pressure in patients with Densiron-68 vs conventional silicone oil: a case-control study. Eye 2009; 23: 190-194
    CrossrefPubMedGoogle Scholar
  • 28 Stappler T, Heimann H, Wong D et al. Heavy tamponade 2 Densiron 68 in routine clinical practice: anatomical and functional outcomes of a consecutive case series. Eye 2008; 22: 1360-1365
    CrossrefPubMedGoogle Scholar
  • 29 Li W, Zheng J, Zheng Q et al. Clinical complications of Densiron 68 intraocular tamponade for complicated retinal detachment. Eye 2010; 24: 21-28
    CrossrefPubMedGoogle Scholar
  • 30 Hussain RN, Banerjee S. Densiron 68 as an intraocular tamponade for complex inferior retinal detachments. Clin Ophthalmol 2011; 5: 603-607
    PubMedGoogle Scholar
  • 31 Romano MR, Angi M, Romano V et al. Intraocular pressure changes following the use of silicone oil or Densiron 68 as endotamponade in pars plana vitrectomy. Clin Ophthalmol 2010; 26: 1391-1396
    PubMedGoogle Scholar